MedTrace Logo

Effect of Aspirin on Abacavir-induced Platelet Reactivity in HIV-infected Patients

NCT03316534 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2017-10-20

No results posted yet for this study

Summary

The specific research questions addressed in the present study are:

* to investigate the impact of treatment with low-dose aspirin in HIV-1-infected patients treated with ABC and test it would result in decreased in vivo platelet activation and platelet hyperreactivity
* to investigate if aspirin has the same effects in HIV-infected as in HIV-uninfected patients.

Conditions

  • HIV-infected Patients

Interventions

DRUG

Aspirin

Aspirin (100 mg once a day)

Sponsors & Collaborators

  • Azienda Ospedaliera di Perugia

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-01-02
Primary Completion
2017-04-30
Completion
2017-10-12

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03316534 on ClinicalTrials.gov